Heba H Mostafa Selected Research

Heba H Mostafa Research Topics

Disease

33	Infections 03/2024 - 12/2013
24	COVID-19 03/2024 - 11/2020
6	Breakthrough Infections 03/2024 - 09/2021
3	Human Influenza (Influenza) 01/2023 - 02/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 01/2018
2	Fever (Fevers) 06/2021 - 03/2021
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2016
1	HIV Infections (HIV Infection) 09/2023
1	Mpox (monkeypox) 01/2023
1	Adenocarcinoma 01/2023
1	Ulcerative Colitis 01/2023
1	Smallpox (Variola) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Cryptogenic Cirrhosis 01/2023
1	Adenoviridae Infections (Adenovirus Infections) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Intraabdominal Infections 01/2022
1	Reinfection 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Asymptomatic Infections 07/2021
1	Respiratory Syncytial Virus Infections 01/2021
1	Latent Infection 01/2018
1	Paramyxoviridae Infections (Parainfluenza) 01/2018

Drug/Important Bio-Agent (IBA)

10	Viral RNAIBA 03/2024 - 01/2021
7	Immunoglobulin G (IgG)IBA 03/2024 - 07/2021
7	VaccinesIBA 03/2024 - 01/2018
5	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2013
5	AntibodiesIBA 01/2022 - 01/2021
5	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
4	AntigensIBA 01/2023 - 03/2021
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2018
3	Oxygen (Dioxygen)IBA 02/2024 - 01/2023
3	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 12/2023 - 01/2023
3	Messenger RNA (mRNA)IBA 03/2023 - 07/2021
3	COVID-19 VaccinesIBA 07/2022 - 09/2021
2	mRNA VaccinesIBA 04/2023 - 01/2022
2	Viral DNAIBA 01/2023 - 01/2023
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 09/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 09/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2023
1	Drug CombinationsIBA 11/2022
1	Ritonavir (Norvir)FDA Link 11/2022
1	nirmatrelvirIBA 11/2022
1	remdesivirIBA 06/2022
1	casirivimab and imdevimab drug combinationIBA 06/2022
1	Neutralizing AntibodiesIBA 01/2022
1	CefiderocolIBA 01/2022
1	SolutionsIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	LuciferasesIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	CytokinesIBA 12/2017
1	Chemokine CCL5IBA 12/2017
1	Oseltamivir (Tamiflu)FDA Link 12/2017
1	Neuraminidase (Sialidase)IBA 01/2017
1	peramivirIBA 01/2017
1	Surface Antigens (Surface Antigen)IBA 02/2016
1	Hemagglutinins (Hemagglutinin)IBA 02/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Phosphotransferases (Kinase)IBA 05/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2014
1	Ubiquitin-Specific ProteasesIBA 05/2014

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2016
1	Art Therapy 09/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018